oa CSIR Science Scope - Using biological expression systems to manufacture therapeutic peptides : oportunities

Volume 6, Issue 3
  • ISSN :



A proprietary biological expression system to manufacture therapeutic peptides is one of the latest CSIR inventions in life sciences. These peptides are generally manufactured by pharmaceutical companies through chemical synthesis and this route can be complex, costly and inefficient. Globally, the use of biological expression systems is finding favour as a low-cost, environmentally friendly alternative to traditional chemical processes. The HaloBiologix™ technology is being further developed at the CSIR and incubated as a potential new start-up venture.

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error